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Abstract
Clinical decision-support systems (CDSSs) comprise systems as diverse as so-
phisticated platforms to store and manage clinical data, tools to alert clinicians of
problematic situations, or decision-making tools to assist clinicians. Irrespective
of the kind of decision-support task CDSSs should be smoothly integrated within
the clinical information system, interacting with other components, in particular
with the electronic health record (EHR). However, despite decades of develop-
ments, most CDSSs lack interoperability features.
We deal with the interoperability problem of CDSSs and EHRs by exploiting
the dual-model methodology. This methodology distinguishes a reference model
and archetypes. A reference model is represented by a stable and small object-
oriented model that describes the generic properties of health record information.
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For their part, archetypes are reusable and domain-specific definitions of clinical
concepts in the form of structured and constrained combinations of the entities
of the reference model. We rely on archetypes to make the CDSS compatible
with EHRs from different institutions. Concretely, we use archetypes for mod-
elling the clinical concepts that the CDSS requires, in conjunction with a series of
knowledge-intensive mappings relating the archetypes to the data sources (EHR
and/or other archetypes) they depend on.
We introduce a comprehensive approach, including a set of tools as well as
methodological guidelines, to deal with the interoperability of CDSSs and EHRs
based on archetypes. Archetypes are used to build a conceptual layer of the kind of
a virtual health record (VHR) over the EHR whose contents need to be integrated
and used in the CDSS, associating them with structural and terminology-based
semantics. Subsequently, the archetypes are mapped to the EHR by means of
an expressive mapping language and specific-purpose tools. We also describe
a case study where the tools and methodology have been employed in a CDSS
to support patient recruitment in the framework of a clinical trial for colorectal
cancer screening.
The utilisation of archetypes not only has proved satisfactory to achieve
interoperability between CDSSs and EHRs but also offers various advantages, in
particular from a data model perspective. First, the VHR/data models we work
with are of a high level of abstraction and can incorporate semantic descriptions.
Second, archetypes can potentially deal with different EHR architectures, due
to their deliberate independence of the reference model. Third, the archetype
3
instances we obtain are valid instances of the underlying reference model,
which would enable e.g. feeding back the EHR with data derived by abstraction
mechanisms. Lastly, the medical and technical validity of archetype models
would be assured, since in principle clinicians should be the main actors in their
development.
Keywords: Clinical Decision Support Systems, Electronic Health Records,
Systems Integration, Clinical Trials, Terminology, SNOMED CT, Artificial
Intelligence.
1. Introduction
A clinical decision-support system (CDSS) can be defined as “any computer
program designed to help health professionals make clinical decision” [1]. This
definition encompasses systems as diverse as sophisticated platforms to store and
manage clinical data, tools to alert clinicians of problematic situations (e.g. drug-
drug interactions), or decision-making tools to assist clinicians by providing pa-
tient-specific recommendations. In a broader sense, other systems which use clin-
ical data to support decisions not directly related to patient care can also be con-
sidered to be CDSSs. Systems to support patient recruitment for clinical research
trials are a representative example of such CDSSs.
Irrespective of the kind of decision-support task, ideally CDSSs should be
smoothly integrated into the computer tools that are routinely used by clinicians,
and more importantly they should be able to operate without the manual entry of
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data already entered using some other system [1]. This implies some interaction
with other components of the clinical information system, in particular with the
electronic health record (EHR) to access all the clinical data required. However,
after more than 3 decades of developments most of CDSSs have been either stand-
alone systems or small components embedded within EHR or physician order
entry systems [1], [2].
An important problem is the heterogeneity of clinical data sources, which may
differ in the data models, schemas, naming conventions, and degree of detail used
to represent similar data [3]. On the other hand, CDSSs very often require data
at a level of abstraction higher than raw clinical data, a problem which has been
referred to as the “impedance mismatch” between the CDSS and the EHR [4],
[5]. There have been several initiatives, involving standardisation bodies, to de-
fine generic EHR architectures for the communication of health data, such as
CEN/ISO EN13606 [6], openEHR [7], HL7 CDA [8], or CDISC ODM [9]. How-
ever, their use is not widespread in current CDSSs.
One of the main contributions of recent EHR architectures is the dual-model
methodology [10] for the description of the structure and semantics of health data.
The dual model methodology distinguishes a reference model and archetypes. A
reference model is represented by a stable and small object-oriented model that
describes the generic properties of health record information (such as folder, doc-
ument, section, and audit). The generality of the reference model (RM) is comple-
mented by the particularity of archetypes. An archetype is a detailed, reusable and
domain-specific definition of a clinical concept (such as Apgar score, discharge
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report, and primary care EHR) in the form of a structured and constrained combi-
nation of the entities of the RM. The principal purpose of archetypes is to provide
a powerful way of managing the description, creation, validation and querying of
EHRs. From a data point of view, archetypes are a means for providing structural
and terminology-based semantics to data instances that conform to some RM.
We deal with the interoperability problem of CDSSs and EHRs by exploiting
dual-model EHR architectures. In previous articles we propose a solution that
exploits openEHR archetypes for the interoperability of CDSSs based on clini-
cal guidelines [11], [12]. In this article we take a further step and describe the
implementation of a prototype that demonstrates the feasibility of our proposal.
The prototype is based on a case study dealing with the determination of patient
eligibility in a clinical trial (CT) for colorectal cancer screening. Typically, both
clinical guideline recommendations and CT eligibility criteria are intended to be
shared across different institutions, at national or even at international level, and
thus the standardised access to the EHR becomes a pressing need in CDSSs for
these purposes.
2. Background
The advantages of integration with the EHR were already acknowledged in
early CDSSs. Thus, different authors have sought such integration while pursuing
the shared use of CDSSs, in particular in guideline-based CDSSs. One of the
early approaches was to separate the site-specific data references from the logic
rules. The best example of this approach is the Medical Logic Modules (MLM)
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of Arden syntax [13], [14], currently a HL7 standard for representing clinical
logic. In Arden Syntax MLMs, the site-specific mappings (queries) to EHR data
are defined in a separated section, known as the data section. In this section, the
specific details for retrieving a required data element from a data source, such as
an EHR, are enclosed in a pair of curly braces. The problem of combining site-
specificity with a standard syntax has been known as the “curly braces problem”.
The problem of combining data residing at different sources and providing a
unified view of these data, known as data integration [15], is not exclusive of the
health-care domain. Among the different approaches to data integration, feder-
ated information systems are the most widely used. These systems leave data at
the sources and provide querying access to the set of data sources through a vir-
tual federated view (schema). The federation relies on schema mapping for the
integration of data sources. The mediator/wrapper architecture [16] is one of the
most commonly used approaches to achieve data federation. A mediator is a read-
only virtual database which is introduced between the data sources and the client
applications and is capable of answering queries about the underlying data [17].
Starting from the federated approach, other initiatives rely on the definition
of a global virtual schema, known as Virtual Medical Record or Virtual Health
Record (VHR), over a set of local EHR systems, and on a set of mappings from
the VHR to the local EHR systems. The VHR includes an information model that
defines generic concepts (such as Observation, Instruction, etc.) for representing
patient data, domains for attributes in the information model (e.g. terminologies),
and a query language [18]. Queries for patient data in the CDSS are posed against
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the VHR schema. In order to answer them they are translated into an equivalent set
of local subqueries that are executed against the local data sources, whose results
are then combined. This approach alleviates the curly braces problem since it
is only necessary to define the mappings between the VHR and the CDSS once.
When a CDSS is to be bound to a new EHR system, only the mappings between
the EHR system and the virtual view are needed, thus the CDSS remains unaltered
and its portability is facilitated.
3. Approach
We are concerned with the use of archetypes within CDSSs as a standard-
ised mechanism for the interaction with the EHR, in order to obtain CDSSs that
can be shared across institutions without the need for modifications in the imple-
mentation. This problem is mentioned by Sujansky as one of the heterogeneous
database integration challenges in Medical Informatics [3], and is usually solved
by means of abstractions that make the CDSS compatible with clinical databases
from different institutions. We propose to use archetypes to build a semantically-
rich VHR for this purpose. More precisely, our proposal is to develop a series of
archetypes for the data/concepts that the CDSS requires, and to include references
to these archetypes in the parts of the CDSS knowledge base (KB) where interac-
tions with the EHR should occur. It is important to note that our interest in shared
use (and reuse) is not limited to the KB as a whole but also covers the archetypes
modelling the necessary clinical data/concepts.
We are also concerned with technical solutions to implement our approach.
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Technical implementation requires on one hand a platform for the access to the
EHR data via archetypes, in the likely case that the EHR does not support ar-
chetypes natively. On the other hand, an inference engine supporting the use of
archetypes is required. For the former, we have used the data integration engine
of the LinkEHR Normalization Platform [17] (see section 4 for more details).
With respect to the inference engine, in the absence of engines that support data
access via archetypes, we have chosen to use an existing guideline execution en-
gine in combination with a specific mediator module which allows taking input
data from a variety of external data sources. Concretely, we have used the Tallis
Engine, which is a non-commercial execution tool for the PROforma guideline
representation language [19]. PROforma is particularly powerful with regard to
decision models [20], [5] which makes it very well-suited for describing the eli-
gibility criteria of our case study. Lastly, as archetype framework we have chosen
the proposal by the openEHR Foundation [7], [21], which stands out for its web-
based repository of reusable archetypes. Figure 1 depicts the overall architecture,
showing the PROforma and LinkEHR modules involved. Notice that despite our
particular choices of PROforma and openEHR, our approach is rather generic.
The architecture is particularly well adapted to CDSSs, which usually require
performing a series of operations or abstractions on the EHR data and subse-
quently using these elaborated data to provide the decision support itself. The
previous operations/abstractions can be resolved by the LinkEHR modules, based
on a series of predefined mappings, while the decision support tasks can be per-
formed by the inference engine. An important feature is that the LinkEHR trans-
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formations are applied to data from clinical databases working under the closed
world assumption, which allows us to conclude e.g. that the patient does not suffer
from a condition unless it has been documented in the EHR. Handling negation
at this level can be advantageous e.g. if the inference engine of choice works un-
der the open world assumption. Finally, note that although we employ medical
terminologies/ontologies for mapping purposes, advanced reasoning over these
terminologies is not considered a priority and therefore is beyond the scope of
this work.
Inference Engine
(e.g. Tallis Engine)
KB,
archetype-
enabled
LinkEHR
Transformation Engine 
+ Extract Server
KB archetypes
(incl. mappings)
LinkEHR
Integration Engine
KB editor
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LinkEHR Editor
Archetype
Editor
Mapping
Editor
Mapping 
Compiler
clinical 
DBs
(relational)
clinical 
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(XML)
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openEHR)
Figure 1: An architecture to deal with the interoperability of CDSSs and EHRs using archetypes.
3.1. Linking the CDSS to heterogeneous EHRs
We rely on archetypes to make the CDSS compatible with EHRs from differ-
ent institutions. Concretely, we use archetypes to provide a uniform (and abstract)
interface to clinical data, which can be subsequently used to connect with hetero-
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geneous EHR implementations. This view has several implications in regard to
knowledge modelling:
1. it is necessary to design a collection of archetypes suitable for the decision-
support tasks carried out in the CDSS
2. it is necessary to ensure that the CDSS KB is compliant with these arche-
types
3. it must be ensured that the connection with the desired source EHR (or
clinical databases) via the designed archetypes is feasible
With respect to (1.), to increase the chances of reuse it is important that the
CDSS archetypes are designed considering the available archetypes and standards.
This is consistent with the philosophy of the openEHR archetypes we propose to
use, since by design they are intended for wide reuse. Requirement (2.) is also
crucial since KBs are often modelled without regard to the interaction with the
EHR, which hinders interoperability. Here again, KBs should be modelled taking
into account EHR standards and available archetypes all along. Finally, require-
ment (3.) involves the definition of a series of mappings relating the archetype
elements from (1.) to the corresponding data items in the source EHR. Because
CDSSs often operate on data abstracted from lower-level EHR data, these map-
pings may relate one archetype to several data items (or even other archetypes),
e.g. by means of logical abstractions. Much of the work presented in this article
relates to the design and mapping of archetypes (requirements (1.) and (3.)).
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3.2. The openEHR architecture
The openEHR architecture uses the dual-model methodology for the descrip-
tion of EHR data [22]. A key feature is the separation of clinical knowledge, de-
scribed using archetypes, from the information or recording model, referred to as
the RM. Thanks to this two-level modelling, openEHR-based systems should be
able to easily accommodate changes in clinical concepts, which will only require
modifications to the archetypes.
An openEHR archetype is a model for the capture of clinical knowledge [23].
It is a machine processable specification of a domain/clinical concept, in the form
of structured constraints and based on the openEHR RM. An archetype exten-
sively describes the structure and content of clinical concepts such as “diagnosis”
or “blood pressure” [24]. In principle archetypes have been defined for wide reuse,
however they can be specialised for adaptation to local singularities. To promote
reuse, archetypes include all the relevant attributes about a specific clinical con-
cept, according to clinicians’ criteria. In this sense, they can be considered as
maximal data sets.
With respect to the openEHR archetype formalisms, we can mention the Ar-
chetype Object Model (AOM), which is an object-oriented model for the represen-
tation of archetypes in memory, and the Archetype Definition Language (ADL),
which is the normative abstract serialisation of archetypes based on F-logic que-
ries with terminology [25]. Other archetype serialisations, e.g. XML-based seri-
alisations, are often used for practical purposes.
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3.3. Reusing openEHR archetypes
When it comes to archetype reuse, it is essential to rely on sources of a certain
quality. We have used the openEHR Clinical Knowledge Manager [26] (CKM),
which is a web-based repository allowing for archetype search, browse and down-
load. Archetypes in the CKM have been created by independent domain experts,
mainly clinicians and computer scientists, and then they have been released to the
community as freely available content. Before publication, archetypes undergo an
iterative review process to ensure that they cover as many use-cases as possible
and thus constitute a reasonable maximal data set (with a high reuse potential).
According to openEHR, the main categories for the description of clinical
concepts are observation, evaluation, instruction and action. This categorisation
is related to the way in which information is created during the care process:
an observation is created by an act of observation, measurement, or testing; an
evaluation is obtained by inference from observations, using personal experience
and/or published knowledge; an instruction is an evaluation-based instruction to
be performed by healthcare agents; and an action is a record of the interventions
that have occurred, instruction-related or not. The number and specificity of ar-
chetypes in the CKM differ significantly among and within categories, possibly
because they have been developed according to individual interests.
For the purposes of our case study we have mainly used the CKM archetype
openEHR-EHR-EVALUATION.problem.v1. It is intended to be used for
recording any information about general health-related problems, understood as
issues that negatively affect the physical, mental and/or social wellbeing of an
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individual. The archetype contains slots for the identifier of the problem, its clin-
ical description, and its severity, as well as for a number of relevant dates (e.g.
date of initial onset, and date clinically recognised), amongst other things. As we
explain later, the archetype openEHR-EHR-EVALUATION.problem.v1 has
been specialised to meet the needs of data sources used in the CDSS of our case
study.
4. Material and methods
4.1. The LinkEHR platform
The LinkEHR Normalization Platform [27] is a set of modules that allow:
i) the creation of an archetype-based customisable view over a set of heteroge-
neous and distributed EHR data sources [17]; ii) the editing of archetypes based
on different RMs (standards), as long as an XML Schema is available [28] (sev-
eral RMs have been tested successfully: CEN/ISO EN13606, openEHR, HL7
CDA, CDISC CDM and CCR); and iii) the specification of declarative mappings
between archetypes and data sources, and from these mappings the automatic gen-
eration of XQuery scripts which translate source XML data into XML documents
that are archetype compliant.
LinkEHR employs archetypes for both the semantic description of legacy
EHRs and the publication of existing clinical information in the form of stan-
dardised EHR extracts. Since health data reside in the underlying EHR systems, it
is necessary to define some kind of mapping information that links entities in the
archetype to data elements in data repositories (e.g. elements and attributes in the
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case of XML sources). Basically, these mappings specify how to create archetype
instances from the content of the data sources.
Different LinkEHR modules are involved in our CDSS interoperability frame-
work (see Figure 1). A crucial tool is the LinkEHR archetype and mapping editor.
During archetype editing, the tool provides support to ensure that the archetype
being edited is valid with respect to the RM (and parent archetype, if any), e.g.
showing the elements allowed [29]. Subsequently, the tool supports both the edit-
ing of archetype-source declarative mappings (through a wide array of transforma-
tion functions, see section 4.2 for more details), and the automatic generation of
adequate XQuery transformation scripts, based on the mapping specifications and
the source schemas. Also important, the LinkEHR integration engine works as a
data integration module that provides a virtual, integrated and global XML view
over distributed clinical data sources, XML or not [17]. Finally, the LinkEHR
transformation engine and the extract server jointly provide an archetype and RM-
compliant extract of the clinical data, from the data supplied by the integration
engine and the above mentioned XQuery scripts.
4.2. Mapping methods in LinkEHR
At the schema level, the above mentioned mappings require an explicit repre-
sentation of how the source schema (either an EHR schema or a set of archetypes)
and target schema (archetype) are related to each other. The effort required to cre-
ate and manage such mappings is considerable. The common case is to write intri-
cate and non-reusable programs to perform the required transformations. This is
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even more complex in the case of archetypes, since they are used to model generic
concepts without regard to the internal architecture of the EHR. LinkEHR allows
the specification of high-level declarative mappings, by defining a set of corre-
spondences between the entities of archetypes and source schemas. Two types
of correspondences are supported, namely value and structural correspondences.
The former specify how to calculate atomic values, whereas the latter may be used
to control the generation and grouping of elements in the target.
In our case study we have primarily used value correspondences. They are
defined by a set of pairs, each consisting of a mapping function that specifies
how to calculate a value in the target from a set of source values, and a condi-
tion that source data must satisfy so that the transformation is applied. References
to source data/schemas are frequent in both mapping functions and conditions.
These may take the form of an XPath location path in the case of XML sources
(i.e. /step/step/...), or an ADL path [25] in case other archetypes are used
as source schemas. With respect to the mapping functions, the simplest kind is the
identity function, which copies a source value into a target value. However, quite
often it is necessary to specify arbitrarily complex functions. For this purpose
the LinkEHR tool comes with a wide range of functions such as type conversion,
as well as mathematical, logical, string, date and time, and metadata functions
(which allow access to archetype metadata such as descriptions or type names).
Additionally, mapping functions can be easily extended. For example, a num-
ber of terminology functions have been added for the interoperability of CDSSs
and EHRs. These functions allow terminology abstraction by reasoning over the
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acyclic taxonomic (is-a) hierarchy of SNOMED CT, among other things (for ex-
amples refer to section 5.5). Aggregation functions have been also added for
interoperability purposes. As illustration we can cite the counting and adding
functions, both operating on a given context (see also section 5.5).
The example in Table I illustrates a simple value correspondence for
transforming gender codes. It transforms the local gender code in the path
/patient/gender of an XML EHR fragment (source data) into a normalised
code to be stored somewhere within an archetype (target data). Note that the
order of mapping specification pairs is relevant, and that only the first applicable
one is used.
Table I: A simple mapping transforming the gender codes from an XML source.
Condition Mapping Function
/patient/gender=‘M’ OR /patient/gender=‘m’ 0
/patient/gender=‘W’ OR /patient/gender=‘w’ 1
/patient/gender=0 OR /patient/gender=1 /patient/gender
true 9
In mapping scenarios with complex nested structures as those induced by EHR
information models, a key aspect is the grouping semantics, i.e. how we have to
group and nest data to build a target instance. LinkEHR comes with a default
grouping semantics based on Partition Normal Form, which has resulted adequate
in many mapping scenarios since it tends to group together data with the same
clinical context (date, author, etc). In those scenarios where this default semantics
is not suitable, structural mappings should be used. In short, structural mappings
define how to generate and group data in the target on the basis of source data [30].
From the set of high-level declarative mapping specifications (value and struc-
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tural correspondences) and archetype constraints, an XQuery script is generated.
The resulting script transforms a source schema instance (EHR data or archetype
instance) into an XML document compliant with both the underlying RM and the
target archetype.
5. Results
5.1. Case study: a CT for colorectal cancer screening
As case study we have used a CT from the ClinicalTrials.gov repository [31],
which is a registry of clinical trials conducted in the US and worldwide. We have
chosen a CT for colorectal cancer screening which has been designed to com-
pare the efficacy of 2 different screening procedures. Concretely, the goal is to
compare the efficacy of biennial immunochemical fecal occult blood test versus
colonoscopy every 10 years for the reduction of colorectal cancer-related mortal-
ity at 10 years in average-risk population [32]. It is an ongoing trial coordinated by
Hospital Clinic of Barcelona (Spain) and conducted in collaboration with several
Spanish hospitals. This particular CT has been chosen on the basis of the com-
plexity of the clinical concepts it requires, e.g. involving definitions in terms of
arithmetic, aggregation and/or logic operations based on other concepts, possibly
complex ones (see section 5.2).
In general, CT inclusion and exclusion criteria can be readily used to imple-
ment a CDSS for patient eligibility determination. Starting exactly from these
criteria, we have implemented a (single decision) CDSS in the PROforma rep-
resentation language. On the other hand, the clinical concepts to which the CT
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criteria refer constitute the minimum data needed for the operation of the CDSS,
and hence requiring archetypes. Furthermore, to make the CDSS work the con-
cepts used in the decision mechanism must be tuned in to the terms and concepts
used in the EHR as far as possible. For instance, one issue is recognising semantic
equivalence in the face of the multiplicity of terms used to describe a disease. This
and other issues justify the need for a shared concept representation [33]. In the
rest of the section we review important aspects related to the PROforma CDSS
for CT patient eligibility and, particularly, to the design and mapping of CT ar-
chetypes. Before that, we give an overview of CT concepts and provide working
definitions thereof.
5.2. Specification and representation of CT concepts
The inclusion and exclusion criteria of the colorectal cancer screening CT
mainly refer to demographic data like sex and age (inclusion of “men and women
aged 50-69 years”), or to data on health problems like colorectal cancer and col-
orectal adenoma (e.g. exclusion of patients with “personal history of colorectal
cancer, colorectal adenoma,...”), which in principle are all expected to be found
in the EHR. An important issue to consider regarding health problems is that CTs
often refer to rather generic conditions describing a wealth of more specific prob-
lems –terminology abstractions according to Peleg et al. [34]. To unravel such
terminology abstractions we have resorted to additional information sources as
well as to UMLS Terminology Services [35], in particular to the SNOMED CT R©
terminology [36].
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Another difficulty is the utilisation of terms that can be defined by means of
more or less complex expressions referring to other lower-level terms –definitions
of abstract terms according to Peleg et al.. To clarify these terms, we have turned
to an Oncology Specialist. A good example is the problem severe comorbidity
(exclusion of patients with “severe comorbidity”), which turned out to be a rather
high-level/abstract concept. Following the definition of the widely used Charlson
index [37], a comorbidity score (and thus a severity grade) can be calculated as
the sum score of the morbidities affecting the patient. A total of 19 morbidities
are considered, ranging from less severe to more severe diseases such as AIDS
and metastatic solid tumor. Among these, several terms corresponded in turn
to complex terms (terminology abstractions or abstract definitions) that required
further analysis.
One of our concerns is the reuse of the archetypes designed for the clinical
data/concepts required by the CDSS (see section 3). To increase reuse chances,
we have gathered the information obtained using the procedure outlined above in
descriptions to document the corresponding archetypes. In order to produce com-
prehensive and unambiguous descriptions, we have employed OWL language [38]
expressions based on SNOMED CT terms whenever it was possible (e.g. in the
case of terminology abstractions). Tables II, III, and IV list the concepts involved
in the CT with their respective informal and formal (OWL) descriptions, both
using SNOMED CT terms. The list of concepts is exhaustive, except for the
lower-level terms on which severe comorbidity is based (in Tables III and IV).
It is noteworthy that we have identified different types of concept descriptions,
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being the most frequent one expressions combining several SNOMED CT terms
using set theory operations such as union (or) and set difference (and not,
i.e. an intersection followed by a complement). Thus, union expressions capture
the specific problems included in two (or more) categories of problems, and set
difference expressions represent the problems that fall in one first category but not
in a second one (see e.g. colorectal cancer and colorectal polyposis in Table II).
Additionally, we have used expressions referring to some SNOMED CT term
with a particular qualifier, typically severity. The previous expressions can be
properly described in OWL. However, complex terms that are calculated based on
the existence of two or more independent problems are not expressible in OWL.
An example is the concept metastatic solid tumor, which depends on the existence
of both a (primary) solid tumor and a secondary tumor or metastasis (see Tables III
and IV).
5.3. Design of a PROforma plan for the CT
A CDSS for patient eligibility determination can be implemented in the PRO-
forma language in a straightforward way. PROforma is among the leading lan-
guages for guideline representation according to the literature [20]. In a wider
sense, it can be considered as a language for modelling clinical processes. In
PROforma these are modelled in terms of hierarchically organised tasks [19].
PROforma tasks fall into four main categories, namely: actions, enquiries, de-
cisions and plans. Actions and enquiries represent the basic interactions with the
environment: actions are used to initiate some external procedure, human or auto-
21
Table II: Description of concepts involved in the case study.
Concept Informal definition using SNOMED CT
terms
OWL definition using SNOMED CT
terms
colorectal adenoma any Adenoma of large intestinea ‘Adenoma of large intestine’
colorectal cancer any Malignant tumor of colona or
any Malignant tumor of rectuma
‘Malignant tumor of colon’ or
‘Malignant tumor of rectum’
colorectal polypo-
sis
any Intestinal polyposis syndromea except
any Polyp of small intestinea
‘Intestinal polyposis
syndrome’ and not ‘Polyp of
small intestine’
familial colorectal
cancer
Family history of cancer of colonb, c N/A
family history of
colorectal polypo-
sis
Family history of polyp of colonb, c N/A
inflammatory
bowel disease
any Inflammatory bowel diseasea ‘Inflammatory bowel disease’
Lynch syndrome Hereditary nonpolyposis colon cancera ‘Hereditary nonpolyposis
colon cancer’
previous total
colectomy
any Total colectomyd ‘Total colectomy’
severe comorbidity Charlson index greater or equal than 6,
calculated as the sum score of the morbidi-
ties of the patient (see lower-level terms in Ta-
ble III)
N/A
aDisorder.
bSituation.
cApproximate definition, due to missing SNOMED CT terms.
dProcedure.
mated, and enquiries serve to obtain information about the environment, be it from
the user or from a database. Decisions are points at which some choice has to be
made based on reasons for and/or against the different alternatives or candidates.
Finally, plans can be used to group together other tasks and are thus a key element
for the hierarchical organisation of tasks. Furthermore, tasks may have a number
of properties that determine the way they will be executed, such as preconditions
and scheduling constraints.
Patient eligibility determination can be implemented in PROforma using
merely one decision task followed by two action tasks corresponding to the
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Table III: Description of concepts required for the definition of severe comorbidity concept.
Concept Informal definition using SNOMED CT
terms
OWL definition using SNOMED CT
terms
AIDS any AIDSa ‘AIDS’
any tumor any Malignant neoplastic diseasea ‘Malignant neoplastic
disease’
diabetes with end
organ damage
any Diabetic neuropathya or
any Diabetic oculopathya or
any Diabetic renal diseasea or
any Peripheral circulatory disorder associated
with diabetes mellitusa, b
N/A
hemiplegia any Hemiplegiaa ‘Hemiplegia’
leukemia any Leukemiaa ‘Leukemia’
lymphoma any Malignant lymphomaa ‘Malignant lymphoma
(clinical)’
metastatic solid tu-
mor
exists any Primary solid tumor and
exists any Metastatic tumor (see lower-level
terms in Table IV)
N/A
moderate or severe
liver disease
any Disease of livera with Severityc
Moderate, Moderate to severe or Severed
‘Disease of liver’
and (‘Severity’ some
(‘Moderate’ or ‘Moderate to
severe’ or ‘Severe’))
moderate or severe
renal disease
any Kidney diseasea with Severityc
Moderate, Moderate to severe or Severed
‘Kidney disease’ and
(‘Severity’ some
(‘Moderate’ or ‘Moderate to
severe’ or ‘Severe’))
aDisorder.
bApproximate definition, due to missing SNOMED CT terms.
cAttribute.
dQualifier values.
exclusion and inclusion outcomes. To illustrate this, Figure 2 shows the key
elements of the PROforma plan for our case study in the PROforma textual
notation. A decision requires the specification of both the candidates of the
decision (in this case, exclude patient and include patient) and the
different arguments for and/or against them. In turn, an argument consists of a
logical expression (e.g. colorectal cancer present = ‘‘true’’)
and a support mode (e.g. for) specifying the conditions under which
a candidate (e.g. exclude patient) must be selected or discarded.
Additionally, a series of recommendation rules for the candidates plus
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Table IV: Description of concepts required for the definition of metastatic solid tumor concept.
Concept Informal definition using SNOMED CT
terms
OWL definition using SNOMED CT
terms
metastatic tumor any Secondary malignant neoplastic diseasea ‘Secondary malignant
neoplastic disease’
primary solid tu-
mor
any Malignant neoplastic diseasea except
any Secondary malignant neoplastic diseasea
except
any Malignant tumor of lymphoid hemopoietic
and related tissuea
‘Malignant neoplastic
disease’ and not (‘Secondary
malignant neoplastic disease’
or ‘Malignant tumor of
lymphoid hemopoietic and
related tissue’)
aDisorder.
a choice mode (single vs. multiple selection) must be specified in the
decision. Finally, to couple the decision with the subsequent actions, the
latter must include a precondition to ensure that they will only be executed
in case the corresponding candidate has been selected in the decision (e.g.
result of(inclusion decision) = exclude patient).
In the above implementation the CT exclusion criteria have been all encoded
as arguments for the candidate exclude patient. These arguments contain a
logical expression that refers to data elements coming from (or derivable from) the
EHR, such as colorectal cancer present. The LinkEHR transformation
engine is the module responsible for providing a value for these data elements, in
accordance with the specified mappings (see section 5.5). The final decision is
calculated by counting all the arguments for the candidate exclude patient,
resulting in the exclusion of the patient if the number of arguments for this
candidate is equal or greater than one (exclude patient recommendation
is netsupport(inclusion decision, exclude patient) ≥ 1).
Conversely, the inclusion decision is made if the number of arguments for the
24
/** PROforma (plain text) version 1.7.0 **/
plan :: ’NCT00906997_plan’ ;
caption :: "NCT00906997_plan" ;
description :: "" ;
component :: ’NHC_enquiry’ ;
caption :: "NHC_enquiry" ;
task_definition :: ’NHC_enquiry’ ;
component :: ’main_enquiry’ ;
caption :: "main_enquiry" ;
task_definition :: ’main_enquiry’ ;
schedule_constraint :: completed(’
NHC_enquiry’) ;
component :: ’inclusion_decision’ ;
caption :: "inclusion_decision" ;
task_definition :: ’inclusion_decision’ ;
schedule_constraint :: completed(’
main_enquiry’) ;
component :: ’include_patient_action’ ;
caption :: "include_patient_action" ;
task_definition :: ’include_patient_action
’ ;
schedule_constraint :: completed(’
inclusion_decision’) ;
component :: ’exclude_patient_action’ ;
caption :: "exclude_patient_action" ;
task_definition :: ’exclude_patient_action
’ ;
schedule_constraint :: completed(’
inclusion_decision’) ;
end plan.
action :: ’exclude_patient_action’ ;
caption :: "exclude_patient_action" ;
precondition ::result_of(inclusion_decision) =
exclude_patient;
end action.
action :: ’include_patient_action’ ;
caption :: "include_patient_action" ;
precondition ::result_of(inclusion_decision) =
include_patient;
end action.
decision :: ’inclusion_decision’ ;
caption :: "inclusion_decision" ;
candidate :: ’include_patient’ ;
recommendation ::netsupport(
inclusion_decision, exclude_patient)
< 1;
candidate :: ’exclude_patient’ ;
argument :: for,colorectal_adenoma_present
= "true" attributes
argument_name :: ’
exclude_patient_Arg_04’ ;
end attributes ;
argument :: for,colorectal_cancer_present
= "true" attributes
argument_name :: ’
exclude_patient_Arg_05’ ;
end attributes ;
...
argument :: for,severe_comorbidity_present
= "true" attributes
argument_name :: ’
exclude_patient_Arg_09’ ;
end attributes ;
recommendation ::netsupport(
inclusion_decision, exclude_patient)
>= 1;
end decision.
enquiry :: ’main_enquiry’ ;
caption :: "main_enquiry" ;
source :: ’colorectal_adenoma_present’ ;
caption :: "colorectal_adenoma_present?" ;
data_definition :: ’textType’ ;
source :: ’colorectal_cancer_present’ ;
caption :: "colorectal_cancer_present?" ;
data_definition :: ’textType’ ;
...
source :: ’severe_comorbidity_present’ ;
caption :: "
severe_comorbidity_present?"
;
data_definition :: ’textType’ ;
end enquiry.
...
Figure 2: Details of the PROforma plan for CT patient eligibility determination.
same candidate is less than one (include patient recommendation is
netsupport(inclusion decision, exclude patient) < 1).
5.4. Design of CT archetypes
The case study requires the design of a series of archetypes suitable for the
decision-support tasks carried out in the above PROforma plan. In this stage we
have used as a tool the LinkEHR archetype editor. As already mentioned, we
have started from the CKM archetype openEHR-EHR-EVALUATION.prob-
lem.v1, which fits well with the kind of clinical concepts identified in the CT
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(see section 5.2). The archetype has been specialised to meet the data needs
of the PROforma plan. This specialisation, named openEHR-EHR-EVAL-
UATION.problem-DS.v1, incorporates a boolean element to store the
presence/absence of the problem plus a numeric element to record the associated
comorbidity score, if required. The latter archetype has been in turn specialised
in a number of specific archetypes, one for each of the identified concepts (i.e.
openEHR-EHR-EVALUATION.problem-DS-colorectal cancer.v1,
and so on). In this way we seek to achieve a “separation of concerns” in the
design of archetypes, and ultimately to facilitate the subsequent mapping process.
Note that although from a definitional point of view some of the concepts are
based (and hence depend) on another, the corresponding archetypes have been
designed as independent objects.
5.5. Mapping of CT archetypes to a summary health record
The archetypes from the previous step are conceived to connect the PROforma
CDSS with alternative EHRs. To accomplish this, we have used the LinkEHR
archetype mapping tool to define a set of mappings relating the (target) archetype
elements to the (source) data items of the EHR under consideration. The EHR
schema that we have chosen in our case study is part of a normalisation project
carried out at Hospital de Fuenlabrada (Spain). The schema has been designed
as a summary health record and integrates the list of problems and medications
of the patient, as reflected in different health information systems (primary care
systems, hospital systems, and medication databases) [39]. The only difference
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with respect to the schema in use at Hospital de Fuenlabrada (HF) is that we
assume a SNOMED CT encoding of patient problems.
For mapping purposes we can make a distinction between the archetypes cor-
responding to terminology abstractions and those corresponding to definitions of
abstract terms. The former have been termed first-level/base archetypes, since
their value can be obtained directly from EHR data by means of rather simple
expressions. The latter, which require data that can be derived from the EHR but
are not available as such, have been named depending on the level of the arche-
types they use as source. E.g. second-level archetypes use first-level archetypes
(and possibly EHR data items), and so forth. Figure 3 depicts the dependences
among the different archetypes and/or the EHR. Although not strictly necessary,
the mapping process was carried out starting with first-level archetypes and con-
tinuing with second-level ones, and so forth. Thereby we were able to validate at
each step the XQuery transformation script generated by the LinkEHR mapping
tool.
As an illustration, Table V shows part of the mapping functions for the
first-level archetype openEHR-EHR-EVALUATION.problem-DS-metas-
tatic tumor.v1, which uses HF summary health record as source schema.
Concretely, this mapping corresponds to the boolean element storing the
presence/absence of a metastatic tumor. According to the definition listed
in Table IV, this problem is present if the patient record stores any problem
within the category ‘Secondary malignant neoplastic disease’.
The mapping condition checks the number of occurrences of such problems,
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...
EHR
...
problem-DS-
colorectal_adenoma
(1st level, 
term. abstraction)
problem-DS-AIDS
(1st level, 
term. abstraction)
problem-DS-
metastatic_tumor 
(1st level, 
term. abstraction)
problem-DS-
colorectal_polyposis
(1st level, 
term. abstraction)
problem-DS-any_tumor
(1st level, 
term. abstraction)
problem-DS-
comorbidity
(3rd level, 
abstract term)
problem-DS-solid_tumor
(1st level, 
abstract term)
problem-DS-
diabetes_with_EOD 
(1st level, 
abstract term)
problem-DS-
metastatic_solid_tumor
(2nd level, 
abstract term)
problem-DS-
colorectal_cancer 
(1st level, 
term. abstraction)
Figure 3: Graphical representation of archetype dependences in terms of the sources they use.
Note that the full archetype names include the prefix openEHR-EHR-EVALUATION. as well as
the suffix v1.adl.
if greater than zero, in both primary care problems (in the archetype path
$context/resumida/problemas OMI/problema OMI) and hospital
ones (in $context/resumida/problemas SELENE/problema SELE-
NE). The path expressions use the variable $context, which refers to a path
in the source and sets the context of the data for a particular patient. Note also
that two parameters are used in @count expressions: the context to be used for
counting and a condition specifying the elements to be counted. Additionally,
the expression @descendents("128462008") has been used to obtain the
SNOMED CT codes for the category itself and for all of its subcategories.
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Table V: A mapping transforming the problem codes from an XML summary health record to
a boolean value indicating the presence/absence of a metastatic tumor. This mapping corre-
sponds to the first-level archetype openEHR-EHR-EVALUATION.problem-DS-metasta-
tic tumor.v1.
Condition Mapping Function
(@count($context/resumida/problemas_OMI/problema_OMI,
@in($context/resumida/problemas_OMI/problema_OMI/codigo,
@descendents("128462008"))) +
@count($context/resumida/problemas_SELENE/problema_SELENE,
@in($context/resumida/problemas_SELENE/problema_SELENE/codigo,
@descendents("128462008")))) > 0
TRUE
TRUE FALSE
Table VI shows the mappings for the presence/absence element of a second-
level archetype, namely openEHR-EHR-EVALUATION.problem-DS-met-
astatic solid tumor.v1. In this case, the element value depends
on the presence of both a primary solid tumor and a metastatic one (see
definition in Table III). The latter information is derived from the HF summary
health record by means of the mappings defined for the first-level archetypes
openEHR-EHR-EVALUATION.problem-DS-solid tumor.v1 and
openEHR-EHR-EVALUATION.problem-DS-metastatic tumor.v1.
Consequently, these archetypes have been used as data sources in the
mapping of openEHR-EHR-EVALUATION.problem-DS-meta-
static solid tumor.v1. Notice that in this case the mapping conditions
can be hard to read, due to the fact that archetypes are used as sources. However,
in practice the user relies on an editing tool that allows entering archetype paths
by simply browsing the archetype nodes and clicking on the appropriate one (e.g.
in all openEHR-EHR-EVALUATION.problem-DS.v1 specialisations, the
path ending with [at0000.1.1]/data[at0001]/items[at0.12]-
29
/value[at0.13]/value points to the boolean value storing the
presence/absence of the problem).
Table VI: A mapping transforming the presence/absence values of two source archetypes
to a boolean value indicating the presence/absence of a metastatic solid tumor. This
mapping corresponds to the second-level archetype openEHR-EHR-EVALUATION.prob-
lem-DS-metastatic solid tumor.v1.
Condition Mapping Function
(/entity_data_root[ENTITYDATAROOTat]/ ...
problem_ds_metastatic_tumor___v1[at0000.1.1]/data[at0001]/
items[at0.12]/value[at0.13]/value = "true") AND
(/entity_data_root[ENTITYDATAROOTat]/ ...
problem_ds_primary_solid_tumor___v1[at0000.1.1]/data[at0001]/
items[at0.12]/value[at0.13]/value = "true")
TRUE
TRUE FALSE
6. Discussion
We have developed all the necessary components to implement a prototype
for the determination of patient eligibility in the framework of a CT for colorectal
cancer screening, which is designed to operate by taking as input patient data as
stored in a real-life EHR system. Firstly, we have implemented a CDSS for patient
eligibility determination in the PROforma language, using basically one decision
element. Second, we have developed a set of openEHR archetypes tailored to the
clinical concepts in the CT and at the same time suitable for the decision-support
tasks of the CDSS. Third, starting with an EHR schema in use in a Spanish hos-
pital, we have defined the necessary mappings to generate archetype-compliant
instances for use in the PROforma CDSS. Finally we have performed a series of
tests of the prototype, checking mainly the proper functioning of the instance gen-
eration scripts created by LinkEHR but also the smooth access of the PROforma
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execution engine to the generated archetype instances. For the latter we have em-
ployed a mediator module which allows connecting the engine with any kind of
external data source, including (XML) archetype instances.
Representation of clinical concepts. As representation language for the
description of clinical concepts, we have used jointly the OWL language and
the SNOMED CT terminology. In most cases we have obtained adequate
OWL+SNOMED CT expressions. Exceptions are a few terms that are not
included in SNOMED CT (e.g. family history of cancer of rectum), surely
for well-founded reasons at the discretion of the developers, and some
definitions of abstract terms using arithmetic or logical expressions beyond the
expressive power of OWL (e.g. metastatic solid tumor would require existential
quantification over two variables). Concerning the lack of a SNOMED CT
concept for specific terms, the preferred solution in our approach is to use
post-coordination at the SNOMED level. An additional option to consider
is using post-coordination at the archetype level. As regards to the OWL
language, it is well-suited to describe terminology abstractions as well as concept
definitions based on set theory operations. However, it is clear that an alternative
language has to be used to meet the needs of other kind of definitions. On the
other hand, in our view the choice of SNOMED CT is beyond question, as it has
recently emerged as global standardised terminology.
Design of archetypes. With regard to the archetypes developed, we have
chosen to keep the entire structure of the archetype used as starting point
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(openEHR-EHR-EVALUATION.problem.v1) in our specialisations. In this
way we intend to leave open the possibility of reuse of our archetypes in other
different contexts, e.g. by applications in health-care settings. Moreover, the
archetypes correspond to actual clinical concepts, which should also increase the
chances of reuse. To support reuse, the definitions we have obtained in the stage
of concept analysis can be of great help if included as documentation within the
archetypes. Although we have not yet provided a solution for this, the option
under consideration is to incorporate an additional element to our specialisations.
Mapping of archetypes. Likewise, concept definitions are crucial in the mapping
stage. As shown in section 5.5, the expressions in mapping conditions bear some
resemblance with the definitions of the corresponding clinical concepts. For in-
stance, an informal concept definition like ‘any <disease>’ must be trans-
lated into an expression to determine whether a patient suffers from any problem
within the category <disease>, including subcategories. This results in the
following expression pattern, which checks the number of occurrences of these
problems among the values of a particular element and for a given context:
@count(<context>, @in(<ehr-element>,
@descendents(<disease-SNOMED-code>))) > 0
Such mapping expressions, which in our case seem to be characteristic of
first-level archetypes, can be reused to a large extent when mapping the
archetypes to other EHRs, by replacing the EHR-specific parts (i.e. <context>
and <ehr-element>). The situation is more favourable in the case of second
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and further level archetypes, which do not depend on the EHR but on other
archetypes. Consequently, the mappings we have developed can be reused as
they are. An important issue to resolve in this case concerns visualisation, since
resulting expressions when (possibly multiple) archetypes are used as source can
be difficult to read.
To conclude discussion on mapping issues, it is worth noting that although
archetypes are defined as maximal data sets, with slots for any data item that
can be possibly required for a concept, the mapping definitions do not have to
be necessarily exhaustive. This is because mapping is only required for those
archetype nodes which have been defined as mandatory in either the RM, the
parent archetype, or the archetype itself.
Prototype tests. We have carried out a series of tests of the archetype instances’
generation scripts created by LinkEHR. These tests have been limited to simulated
data, although using an EHR schema currently in production in a Spanish hospital.
Our tests have shown that the response time of queries is affordable. However,
more comprehensive tests in a realistic setting are still pending. On the other hand,
the tests have served to debug and validate the add-ons implemented specifically
for our case study, and ultimately as a proof-of-concept of our approach. The
add-ons are all new LinkEHR functionalities, falling into two main categories:
new functions for the description of mappings, and integrated support for using
archetypes as data sources.
Some of the new LinkEHR mapping features have proven to be crucial for
our purposes. One is the implementation of a basic SNOMED CT query module
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(limited to the is-a relationships), which allows to refer to e.g. the descendants
of a given concept/category in mapping expressions (the previously mentioned
@descendents function). Even more important is the possibility of using mul-
tiple archetypes as source schema. This feature has been extensively used in our
case study, and is expected to continue to be so in other CDSS interoperability
projects.
Scope and limitations of this work. The approach presented in this article has
been put into practice in a case study for CT patient recruitment, resulting in a
prototype with the desired interoperability characteristics. Despite having used
a single case study, the approach is rather generic and thus applicable to other
CDSSs, possibly in other clinical domains. To take one example, the approach is
currently being successfully applied to a CDSS for colorectal cancer risk assess-
ment, which is based on the results of colonoscopy (and other) tests and there-
fore requires completely different clinical parameters. In this case the definitions
of complex concepts use aggregation functions such as counting and maximum,
which are within the functionalities of LinkEHR. It should be noted that no new
functionalities were needed for this CDSS. LinkEHR has also proved satisfactory
in applications that handle numerical data, e.g. dealing with the numerical values
and units of medication information [30]. In our experience, the concept defini-
tions involved in our case study (some beyond the expressive power of OWL) are
among the hardest to deal with for the interoperability of CDSSs and EHRs.
In principle the proposed approach can fit in service-oriented environments
where a CDSS is offered as a set of services [40]. In such environments one of the
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most important services is the decision support one, which receives patient data
as input and produces a set of patient-specific conclusions as output. Other useful
services are the common terminology service or the entity identification one. The
mapping and abstraction capabilities presented in this article could be encapsu-
lated as a service providing standardisation and abstraction functionalities. This
service would offer operations at the concept model level (and also at the infor-
mation model one), thus making decision support independent of the particular
details of clinical data sources.
One limitation of our work is the basic SNOMED CT reasoning we use, re-
stricted to reasoning over the is-a hierarchy of concepts. This has been sufficient
for terminology abstractions and for concept definitions using set operations, but
would not be enough if more advanced support is required. An example could
be to determine if two SNOMED CT expressions, e.g. pre- and post-coordinated
ones, are equivalent. If this is a requirement, we envisage the integration of an
external reasoning service providing an adequate support within our architecture.
7. Related work
Standardisation of the VHR is regarded as an important issue [18], particu-
larly in the definition of the VHR global schema. Several initiatives have based
their VHR on standard EHR architectures. The use of a simplified version of HL7
RIM is the prevailing option. The KDOM framework [34], the MEIDA architec-
ture [41], and the works by Lonsdale et al. [42] and by Cho et al. [43], [44] are
remarkable examples of this alternative. All these approaches use a VHR based on
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a small subset of HL7 RIM classes, which are also simplified, to make the CDSS
compatible with different EHRs. Although EHR architectures impose a tree-like
structure to health data, these approaches use a flat relational view over the source
EHR to build the VHR. This hides the original semantics of the HL7 RIM, apart
from generating data redundancy in the virtual schema. Another approach, that
stands apart from the previous ones, is the EGADSS system [45]. It uses HL7
CDA for building the VHR, resulting in a more structured VHR. However, it uses
a single type of document (a patient summary) that contains a fixed set of pa-
tient data as VHR. The source EHR systems generate this document in XML in
response to a clinical event, such as the beginning of a patient encounter.
HL7 acknowledges the difficulties of using EHR standards to define VHRs,
and consequently is currently working on the specification of a Virtual Medical
Record (VMR) [46] that aims at facilitating the reuse of exiting healthcare data
in CDSSs. The HL7 VMR is an information model inspired by existing HL7
version 3 standards which has been designed to accommodate non HL7-based
sources as well. It defines a simple model for representing patient data, and at the
same time comes with powerful context specification capabilities. It does not try
to represent every possible entry in the EHR, although it is powerful enough to
represent a large percentage of decision support needs.
The use of a VHR based on a standard EHR architecture is necessary but
not sufficient for semantic interoperability between CDSSs and EHRs. The main
problem is the partitioning of concepts between the information model (EHR ar-
chitecture) and terminology [47], [48]. Every different partition decision yields
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as a result a different valid representation of data with respect to the information
model. In order to solve this problem it is necessary to make explicit all the as-
sumptions about the representation of data. Thus, high-level domain concepts’
descriptions are needed rather than generic concepts as those provided by EHR
architectures. The SAGE project [48], [49] was the first work to consider this
problem. They proposed the use of Detailed Clinical Models (DCMs) as a way
of defining explicitly the unique data representation expected by the guidelines.
In SAGE the VHR is composed of a set of DCMs, all of them derived from the
information model classes by constraining the value of properties. Each DCM
describes a particular domain concept, such as diagnosis or blood pressure mea-
surement, needed by the CDSS. In SAGE, as in most of the previous initiatives,
the information model is composed of a subset of HL7 RIM classes which are
also simplified. SAGE DCMs are also employed by Lonsdale et al. for evaluat-
ing CT eligibility criteria against EHR systems. DCMs are similar in purpose to
archetypes or CDA templates in many ways [50].
Our approach is similar to the idea of these latter platforms which both use
clinical models for specifying the VHR. Two distinctive features of our work are
i) the utilisation of the full-fledged archetype framework (including inheritance,
reutilisation and composition of archetypes, semantic validation, and terminology
bindings) for specifying the VHR instead of simple unrelated concept definitions,
and ii) the support for any information model, as long as an XML Schema is
available, instead of a fixed simplified one as in the previous platforms. Figure 4
compares the main approaches, specifically: those requiring substantial CDSS
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modifications (see (a) in Figure 4), like the Arden Syntax, those exploiting a
VHR based on some generic EHR architecture (see (b)), like KDOM or MEIDA,
and finally those that make use of domain concepts for defining the VHR (see
(c)), as our approach.
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Figure 4: Linking a CDSS to different EHRs (adapted from Fig. 1 by Peleg et al. [34]): (a) adapt-
ing the CDSS to each EHR; (b) through data views based on (a subset of) HL7 RIM; and
(c) through reusable concept views based on archetypes (e.g. openEHR).
Mapping source EHR data to the CDSS is a very complex task, due to the
differences and mismatches between heterogeneous formats, models, abstractions
levels, and semantics. In the case of a generic VHR (as in KDOM or MEIDA),
two levels of mappings have to be considered: from the EHR to the VHR, and
from the VHR to the CDSS. The construction of the VHR from the source EHR
is a manual process in all the projects that use a generic VHR. In our approach the
VHR is composed of a set of domain concepts (archetypes) tailored to a particular
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CDSS, although with a high potential of reuse between different CDSSs, and at
the same time based on a generic information model. Since our VHR is composed
of a set of concepts, the same tools and mapping language are used throughout the
whole mapping process, from raw EHR data to the potentially highly abstract
CDSS concepts. The mapping capabilities differ also a lot among the analysed
projects. EGADSS only supports basic one-to-one mappings expressed in XPath,
and the approach by Cho et al. provides very basic concept-level mappings. The
approach by Lonsdale et al. only supports the definition of abstract terms from
basic concepts. MEIDA supports powerful temporal abstractions but basic termi-
nology ones, and provides no support for mapping composition and/or reutilisa-
tion. KDOM provides terminology abstractions and definition of abstract terms,
as well as mapping composition and reutilisation, but only supports basic tempo-
ral abstractions. Thanks to the LinkEHR platform, our approach provides support
for all the previous mapping capabilities. This includes structural mappings, i.e.
mappings that rule structural transformations between complex structures such as
classes of information models. Note that no other approach supports this feature,
which has proved essential for our purposes. Table VII summarises the solutions
and capabilities provided by the main approaches we have analysed.
8. Conclusions
In this article we introduce a comprehensive approach, including a set of tools
as well as methodological guidelines, to deal with the interoperability of CDSSs
and EHRs based on archetypes. Archetypes are used to build a conceptual layer
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Table VII: Comparative analysis of the main approaches to interoperability of CDSSs and EHRs
using a VHR (in chronological order).
Features EGADSS KDOM Lonsdale et
al.
MEIDA Cho et al. our ap-
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H
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HL7-RIM
Subset of
HL7-RIM
Subset of
HL7-RIM
Subset of
HL7-RIM
any
VHR generation
from EHR
manual manual manual manual Semi-
automatic
from
high-level
declarative
mappings
Semi-
automatic
from
high-level
declarative
mappings
Clinical models
in VHR
no no yes, De-
tailed
Clinical
Models
no no yes, arche-
types
VHR instances XML in-
stances of
the Patient
Summary
Document
Flat re-
lational
view of
HL7-RIM
Nested
name-
value
pairs
Flat re-
lational
view of
HL7-RIM
Flat re-
lational
view of
HL7-RIM
XML in-
stances
compli-
ant with
reference
model and
clinical
models
M
ap
pi
ng
fe
at
ur
es
&
m
ap
pi
ng
ty
pe
s
High-level
declarative map-
ping language
no yes no yes basic yes
Mapping execu-
tion language
XPath SQL proprietary SQL SQL XQuery
Extension of
mapping func-
tions
no yes no no no yes
Structural map-
pings
no no no no no yes
Concept-level
mappings
no no (just
attribute
level)
yes no (just
attribute
level)
basic yes
Mapping compo-
sition
no yes no no no yes
Mapping reutili-
sation
no yes no no no yes
Terminology ab-
stractions
no yes no yes no yes
Temporal ab-
stractions
no basic no yes no basic
Definition of ab-
stract terms
no yes yes no no yes
Q
ue
ry
Automated query
generation
no yes yes yes yes yes
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of the kind of a VHR over the EHR whose contents need to be integrated and used
in the CDSS, associating them with structural and terminology-based semantics
–what might be termed knowledge-rich clinical models based on archetypes. Sub-
sequently, the archetypes are mapped to the EHR by means of an expressive map-
ping language and specific-purpose tools. In the article we also describe a case
study where the tools and methodology have been employed in a CDSS to support
patient recruitment in the framework of a CT for colorectal cancer screening.
The utilisation of archetypes not only has proved satisfactory to achieve inter-
operability between CDSSs and EHRs but also offers benefits of varying nature.
From a data model perspective, the utilisation of archetypes brings about several
advantages over similar initiatives. First, the VHR/data models we work with are
of a higher level of abstraction (clinical concept level instead of RM one) and
can incorporate semantic descriptions (through terminology references). Second,
archetypes can potentially deal with different EHR architectures (e.g. CEN/ISO
EN13606, openEHR or HL7 CDA), due to their deliberate independence of the
RM. Third, no matter what RM is used, the archetype instances we obtain are
valid instances of the underlying RM, which would enable e.g. feeding back the
EHR with data derived by abstraction mechanisms. Lastly, the medical and tech-
nical validity of archetype models would be assured, since in principle clinicians
should be the main actors in their development.
In the future we intend to work on different kinds of enhancements to our
approach. On one hand we plan to integrate methodologies and tools to deal with
an explicit domain (or concept) model, as well as with the interactions thereof
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with the archetype (or information) model, in line with the conceptual framework
proposed by Rector [47]. On the other hand we envisage to deal with efficiency
issues, to ensure that the response time when handling realistic clinical databases
is affordable. Also related to the functionalities of our tools, we plan to address
the bidirectional interaction of the CDSS with the clinical information system, e.g.
the CDSS feedback to the EHR which has been mentioned above.
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